Glycated hemoglobin (HbA1c) levels reflect average blood glucose control over the preceding two to three months. Maintaining appropriate glycemic control in older adults is essential for minimizing the risk of diabetes-related complications. For instance, a physician might aim for a specific range to balance the risks of hypoglycemia with the benefits of preventing long-term complications.
Effective glycemic management in this population is crucial due to the increased prevalence of comorbidities and age-related physiological changes that can affect glucose metabolism and increase vulnerability to both hyperglycemia and hypoglycemia. Historically, strict glycemic control was emphasized. However, evolving research and clinical experience have led to more individualized targets, recognizing the importance of balancing efficacy and safety in older adults.
This discussion will further explore the complexities of managing blood glucose in older individuals, considering factors such as age, comorbidities, functional status, and patient preferences to determine the most appropriate individualized approaches. Topics will include the risks and benefits of different management strategies, the role of lifestyle interventions, and the importance of regular monitoring and assessment.
1. Individualized Targets
Individualized HbA1c targets represent a cornerstone of effective glycemic management in older adults. A “one-size-fits-all” approach is often inappropriate due to the heterogeneity of this population. Factors such as age, comorbidities, functional status, life expectancy, and patient preferences significantly influence the optimal HbA1c target for each individual. For instance, a relatively healthy 80-year-old with a long life expectancy might benefit from tighter glycemic control, aiming for an HbA1c closer to 7%, to minimize long-term complications. Conversely, a frail 85-year-old with multiple comorbidities and a limited life expectancy might experience more harm than benefit from intensive glycemic control, with an increased risk of hypoglycemia. In this case, a less stringent target, perhaps closer to 8% or even higher, might be more appropriate, prioritizing quality of life and minimizing treatment burden.
The rationale behind individualized targets stems from the need to balance the benefits of glycemic control with the risks of hypoglycemia. Older adults are particularly vulnerable to hypoglycemia due to age-related physiological changes and potential drug interactions. Severe hypoglycemic events can lead to falls, fractures, cognitive impairment, and even death. Therefore, setting overly ambitious HbA1c targets in frail older adults can inadvertently increase the risk of harm. Individualized targets allow clinicians to tailor treatment strategies to each patient’s unique circumstances, optimizing benefits while mitigating risks. Practical application involves a thorough assessment of each patient’s overall health status, functional capacity, and treatment goals, followed by a shared decision-making process that incorporates patient preferences and values.
In conclusion, individualized HbA1c targets are essential for safe and effective diabetes management in older adults. This approach acknowledges the complexity and heterogeneity of this population, emphasizing the need to balance the benefits of glycemic control with the risks of hypoglycemia. Moving away from rigid targets towards a more personalized approach improves patient outcomes, enhances quality of life, and promotes patient-centered care. The ongoing challenge lies in developing clear guidelines and providing clinicians with the tools and resources necessary to implement individualized targets effectively in diverse clinical settings.
2. Age-related factors
Age-related physiological changes significantly influence glycemic control and impact HbA1c targets in older adults. Decreased renal function affects the clearance of medications used to manage diabetes, potentially increasing the risk of hypoglycemia. Reduced hepatic insulin sensitivity can contribute to hyperglycemia. Furthermore, diminished pancreatic beta-cell function limits the body’s ability to produce and release insulin effectively, further complicating glycemic control. These changes necessitate careful consideration when establishing HbA1c targets. For example, an 85-year-old with reduced renal function may require a lower dose of a diabetes medication compared to a 65-year-old with normal renal function, even if both individuals have similar HbA1c levels. Ignoring these age-related changes can lead to inappropriate medication dosing and increased risk of adverse events.
Beyond physiological changes, age-related factors such as cognitive decline and functional limitations can impact an individual’s ability to adhere to complex medication regimens, dietary restrictions, and self-monitoring of blood glucose. These factors influence the feasibility and safety of intensive glycemic control. For instance, an individual with dementia may struggle to remember to take medications or follow a prescribed diet, making strict HbA1c targets challenging to achieve and potentially increasing the risk of both hyperglycemia and hypoglycemia. Similarly, an individual with limited mobility may have difficulty preparing healthy meals or engaging in regular physical activity, both of which are essential for managing blood glucose effectively.
In summary, age-related factors play a crucial role in determining appropriate HbA1c targets for older adults. Physiological changes, cognitive decline, and functional limitations influence both the efficacy and safety of glycemic control. Understanding these factors is essential for individualizing treatment plans and optimizing outcomes in this population. Clinicians must carefully assess each patient’s individual circumstances, considering age-related changes, comorbidities, and functional status to determine the most appropriate and achievable HbA1c target, balancing the benefits of glycemic control with the risks of adverse events. This approach ensures patient safety and promotes a patient-centered approach to diabetes management in older adults.
3. Comorbidities
Comorbidities exert a significant influence on glycemic control and the determination of appropriate HbA1c targets in older adults. The presence of multiple chronic conditions, such as cardiovascular disease, renal disease, and cognitive impairment, can complicate diabetes management and increase the risk of adverse events. For example, individuals with heart failure may experience worsened symptoms with aggressive glycemic control due to fluid retention associated with certain diabetes medications. Similarly, individuals with chronic kidney disease may require adjustments in medication dosages due to impaired drug clearance, highlighting the intricate interplay between comorbidities and diabetes management.
Specific comorbidities can influence HbA1c targets in distinct ways. Cardiovascular disease often necessitates a cautious approach to glycemic control to minimize the risk of hypoglycemia, which can exacerbate cardiac conditions. Chronic kidney disease requires careful medication selection and dosage adjustments to avoid further renal impairment. Cognitive impairment can impact an individual’s ability to manage diabetes effectively, making less stringent HbA1c targets more practical and safe. Consider an individual with both heart failure and moderate cognitive impairment. An overly ambitious HbA1c target could precipitate hypoglycemia, leading to confusion and potentially a fall, while also exacerbating heart failure symptoms. A more moderate target, acknowledging the presence of these comorbidities, minimizes these risks while still providing reasonable glycemic control.
Understanding the impact of comorbidities on HbA1c targets is crucial for personalized diabetes management in older adults. Clinicians must carefully assess the presence and severity of comorbidities when establishing individualized glycemic goals. This requires a holistic approach that considers the potential interactions between diabetes and other chronic conditions, the impact of comorbidities on medication efficacy and safety, and the individual’s overall health status and functional capacity. Recognizing these complex relationships allows for more informed decision-making, optimizing treatment strategies, and reducing the risk of adverse outcomes in this vulnerable population.
4. Functional Status
Functional status plays a pivotal role in determining appropriate HbA1c targets for older adults. This refers to an individual’s ability to perform activities of daily living, such as bathing, dressing, eating, and ambulating. Declining functional status often correlates with increased frailty and vulnerability to adverse events, including hypoglycemia. Individuals with limited functional capacity may struggle with complex diabetes management regimens, such as frequent blood glucose monitoring, multiple medication injections, or adherence to strict dietary plans. For instance, an individual with limited mobility may find it difficult to shop for groceries and prepare healthy meals, potentially hindering optimal glycemic control. Similarly, someone with impaired vision might struggle to accurately measure insulin doses or interpret blood glucose readings.
The relationship between functional status and HbA1c targets is bidirectional. While declining functional status can make achieving tight glycemic control more challenging, intensive diabetes management in frail individuals can inadvertently increase the risk of hypoglycemia, further impairing function and increasing the risk of falls, fractures, and hospitalization. Consider an individual with moderate cognitive impairment and limited mobility. Intensive insulin therapy, while potentially lowering HbA1c, could lead to hypoglycemic episodes causing confusion and falls, exacerbating existing functional limitations. A less stringent HbA1c target, balancing the benefits of glycemic control with the risks of hypoglycemia, might be more appropriate in this context, prioritizing safety and preserving existing functional capacity.
In summary, functional status represents a critical consideration in determining individualized HbA1c targets for older adults. Declining functional capacity often necessitates a more cautious approach to glycemic control, prioritizing safety and minimizing the risk of hypoglycemia-induced functional decline. Assessing functional status requires a comprehensive evaluation of an individual’s physical and cognitive abilities, considering their capacity to manage diabetes effectively and safely. Integrating functional status into the decision-making process ensures a patient-centered approach, balancing the potential benefits of glycemic control with the risks of adverse events in this vulnerable population. This holistic approach promotes well-being and maintains quality of life for older adults living with diabetes.
5. Hypoglycemia Risk
Hypoglycemia risk represents a paramount concern when establishing glycated hemoglobin targets in older adults. Age-related physiological changes, including decreased renal function and reduced hepatic insulin sensitivity, increase susceptibility to hypoglycemia. Furthermore, the presence of comorbidities, such as cardiovascular and renal disease, can exacerbate this risk. Polypharmacy, common in this population, further complicates the situation, as drug interactions can unpredictably alter medication metabolism and increase the likelihood of hypoglycemic events. Aggressive glycemic control, aiming for overly stringent HbA1c targets, can inadvertently elevate hypoglycemia risk, particularly in frail older adults. For example, an individual with impaired renal function taking multiple medications, including insulin, might experience severe hypoglycemia if prescribed an overly ambitious HbA1c target. Consequences can range from confusion and falls to seizures and coma, significantly impacting morbidity and mortality.
The increased vulnerability to hypoglycemia necessitates a cautious and individualized approach to HbA1c targets in older adults. Balancing the benefits of glycemic control with the risks of hypoglycemia is crucial. Prioritizing a patient’s overall well-being and functional status often necessitates a less stringent HbA1c target compared to younger individuals. Clinical judgment, informed by a thorough assessment of each patient’s individual circumstances, including age, comorbidities, functional status, and medication regimen, is essential. Regular monitoring of blood glucose levels, particularly during periods of illness or medication adjustments, is crucial for early detection and prevention of hypoglycemic events. Educating patients and caregivers about the signs and symptoms of hypoglycemia and appropriate management strategies empowers them to take proactive steps to mitigate risk.
In conclusion, hypoglycemia risk represents a critical factor in determining appropriate HbA1c targets for older adults. The interplay of age-related physiological changes, comorbidities, and polypharmacy increases susceptibility to hypoglycemia, particularly with aggressive glycemic control. A balanced approach that prioritizes patient safety and functional status is essential. Individualized targets, informed by comprehensive patient assessments and regular monitoring, minimize the risk of hypoglycemia while still providing reasonable glycemic control. This approach ensures optimal outcomes and enhances quality of life for older adults living with diabetes.
6. Life Expectancy
Life expectancy plays a significant role in determining appropriate glycemic targets in older adults. Balancing the potential benefits of intensive glycemic control with the risks of adverse events requires careful consideration of an individual’s remaining lifespan. Shorter life expectancy may warrant less stringent targets, prioritizing quality of life and minimizing treatment burden, while longer life expectancy may support more intensive management to reduce long-term complications.
-
Projected Lifespan and Treatment Intensity
Individuals with longer projected lifespans may benefit from tighter glycemic control, aiming to prevent long-term microvascular complications such as retinopathy, nephropathy, and neuropathy. These complications can significantly impair quality of life over time. Conversely, individuals with limited life expectancy may experience more harm than benefit from intensive treatment, as the risk of hypoglycemia and treatment burden may outweigh the potential for preventing long-term complications that are unlikely to manifest.
-
Balancing Benefits and Risks
The decision to pursue intensive glycemic control involves a careful balance between potential benefits and risks. For individuals with longer life expectancies, the benefits of reducing long-term complications often outweigh the risks associated with tighter control. However, for those with shorter life expectancies, the risks of hypoglycemia, polypharmacy, and treatment burden may outweigh the potential benefits of intensive management. This underscores the need for individualized treatment plans tailored to each patient’s specific circumstances and projected lifespan.
-
Comorbidities and Life Expectancy
The presence of comorbidities further complicates the relationship between life expectancy and glycemic control. Individuals with multiple comorbidities and limited life expectancy may be particularly vulnerable to adverse events associated with intensive treatment. In these cases, less stringent targets may be more appropriate, prioritizing comfort and quality of life over aggressive glycemic control. Conversely, individuals with fewer comorbidities and longer life expectancies may tolerate and benefit from more intensive management.
-
Shared Decision-Making
Incorporating patient preferences and values is essential when considering life expectancy and glycemic targets. Shared decision-making, involving a collaborative discussion between the clinician and the patient (or their representative if decision-making capacity is impaired), ensures that treatment decisions align with individual goals and priorities. This approach respects patient autonomy and fosters a patient-centered approach to care, balancing clinical evidence with individual circumstances and preferences.
Ultimately, the optimal HbA1c target in older adults considers life expectancy as a critical factor, balancing the potential for long-term benefit with the risks of aggressive treatment. Individualized approaches, incorporating patient preferences and a thorough assessment of comorbidities and functional status, are essential for optimizing outcomes and promoting well-being in this population.
7. Patient Preferences
Patient preferences represent a crucial element in determining appropriate HbA1c targets for older adults. Effective diabetes management requires a patient-centered approach that considers individual values, goals, and priorities. Treatment decisions should reflect a shared understanding between clinicians and patients regarding the benefits and risks of different glycemic targets, acknowledging the potential impact on quality of life. For instance, an individual might prioritize avoiding hypoglycemia over achieving a lower HbA1c target, even if it means a slightly increased risk of long-term complications. Conversely, another individual might prioritize minimizing long-term complications and be willing to accept a higher risk of hypoglycemia to achieve a tighter HbA1c target. These preferences stem from individual values and perceptions of risk and benefit, highlighting the importance of incorporating patient perspectives into treatment decisions.
Ignoring patient preferences can lead to treatment non-adherence and suboptimal outcomes. Imposing treatment plans without considering an individual’s values and goals can create tension and distrust between patients and clinicians. This can manifest as resistance to medication regimens, dietary modifications, or self-monitoring practices. For example, if an individual values independence and autonomy, a complex medication regimen requiring multiple daily injections might be perceived as burdensome and intrusive, leading to poor adherence. Conversely, a collaborative approach that respects patient preferences and incorporates them into treatment planning fosters engagement and improves the likelihood of successful outcomes. Offering choices, providing clear explanations, and actively listening to patient concerns strengthens the therapeutic alliance and promotes a sense of shared responsibility in managing diabetes.
Integrating patient preferences into HbA1c target determination requires effective communication and shared decision-making. Clinicians must actively elicit patient values and priorities, providing clear and unbiased information about the risks and benefits of different glycemic targets. This involves explaining the potential impact of various HbA1c levels on long-term complications and the risk of hypoglycemia. Using decision aids, such as risk calculators and patient testimonials, can facilitate informed choices. Ultimately, the goal is to arrive at a mutually agreed-upon HbA1c target that aligns with the patient’s individual circumstances, values, and preferences. This collaborative approach optimizes treatment adherence, enhances patient satisfaction, and promotes positive health outcomes for older adults living with diabetes.
8. Regular Monitoring
Regular monitoring of glycemic control is essential for effective diabetes management in older adults. It provides crucial insights into the effectiveness of treatment strategies and allows for timely adjustments to maintain optimal HbA1c targets. This proactive approach helps mitigate the risks of both hyperglycemia and hypoglycemia, promoting overall well-being and reducing the risk of long-term complications. Monitoring frequency and methods must be individualized based on patient-specific factors.
-
Frequency of Monitoring
The frequency of HbA1c testing depends on individual factors such as current glycemic control, medication regimen, and the presence of comorbidities. Stable, well-controlled individuals may require less frequent testing (e.g., every 3-6 months), while those with fluctuating glucose levels or initiating new therapies may benefit from more frequent assessments (e.g., every 2-3 months). More frequent monitoring enables timely adjustments to treatment plans, preventing prolonged periods of hyperglycemia or hypoglycemia. For individuals on intensive insulin regimens or experiencing frequent hypoglycemic episodes, self-monitoring of blood glucose (SMBG) may be necessary multiple times daily to inform immediate adjustments to insulin doses and dietary intake.
-
Methods of Monitoring
HbA1c provides a retrospective assessment of average glucose control over the preceding 2-3 months. While valuable for long-term assessment, it does not capture short-term fluctuations. SMBG offers real-time data, enabling immediate adjustments to therapy. Continuous glucose monitoring (CGM) systems provide dynamic glucose data, offering insights into trends and patterns. The choice of monitoring method depends on individual needs and circumstances. For example, CGM might be particularly beneficial for individuals experiencing nocturnal hypoglycemia or those with hypoglycemia unawareness, providing continuous glucose data and alerts to prevent severe events.
-
Interpreting Results and Adjusting Therapy
Regular monitoring data must be interpreted within the context of each patient’s individual circumstances. Factors such as age, comorbidities, functional status, and patient preferences influence the interpretation of HbA1c and SMBG results and guide treatment adjustments. For instance, a slightly elevated HbA1c in a frail older adult with multiple comorbidities might not warrant aggressive treatment intensification, whereas the same HbA1c in a younger, healthier individual might necessitate adjustments to medication or lifestyle interventions. The goal is to maintain glycemic control within a target range that minimizes risks while optimizing individual well-being.
-
Patient Education and Empowerment
Effective monitoring requires active patient participation. Educating patients about the importance of regular monitoring, proper techniques for SMBG, and interpreting results empowers them to actively engage in their diabetes management. Clear communication between patients and clinicians regarding monitoring data and treatment adjustments fosters a collaborative approach, enhancing adherence and promoting positive outcomes. This shared understanding ensures that treatment decisions align with individual goals and preferences. For example, discussing SMBG results with patients helps them understand the impact of diet and exercise on glucose control and encourages self-management strategies.
Regular monitoring, encompassing a range of methods and frequencies tailored to individual needs, serves as the cornerstone of effective glycemic management in older adults. By providing crucial data and informing timely adjustments to therapy, regular monitoring helps achieve and maintain individualized HbA1c targets, minimizing risks and optimizing outcomes in this vulnerable population.
9. Treatment Goals
Treatment goals in managing glycated hemoglobin levels in older adults are intrinsically linked to individualized HbA1c targets. These targets serve as concrete benchmarks guiding therapeutic interventions and reflecting the overall objectives of diabetes management. Establishing appropriate treatment goals requires a comprehensive understanding of an individual’s health status, including age, comorbidities, functional status, and life expectancy. The relationship between treatment goals and HbA1c targets is not simply one of cause and effect; rather, it represents a dynamic interplay where targets inform goals and goals, in turn, influence the feasibility and appropriateness of specific targets. For example, a primary treatment goal for a frail older adult might be to prevent hypoglycemia and maintain functional independence. This goal would necessitate a less stringent HbA1c target compared to a younger, healthier individual whose treatment goal might prioritize minimizing the risk of long-term microvascular complications.
Practical application of this understanding involves a nuanced approach to individualizing both treatment goals and HbA1c targets. Consider an 85-year-old individual with multiple comorbidities, including moderate cognitive impairment and chronic kidney disease. Aggressive glycemic control, aiming for a low HbA1c target, could increase the risk of hypoglycemia, potentially leading to confusion, falls, and further functional decline. In this scenario, a more appropriate treatment goal would be to prevent hypoglycemia and maintain current functional status, even if it means accepting a higher HbA1c target. Conversely, a relatively healthy 70-year-old with a long life expectancy might benefit from tighter glycemic control to minimize the risk of long-term complications, justifying a lower HbA1c target aligned with this goal. Therefore, treatment goals serve as a compass guiding the selection of appropriate HbA1c targets, ensuring that interventions align with individual needs and priorities.
In conclusion, the connection between treatment goals and HbA1c targets in older adults is fundamental to effective diabetes management. Individualized treatment goals, informed by a holistic assessment of patient characteristics and preferences, dictate the appropriateness and feasibility of specific HbA1c targets. This patient-centered approach, emphasizing the interplay between goals and targets, optimizes outcomes, minimizes risks, and enhances quality of life for older adults living with diabetes. Successfully navigating the complexities of this relationship requires ongoing clinical judgment, effective communication, and a commitment to shared decision-making.
Frequently Asked Questions
Addressing common concerns regarding glycemic management in older adults requires clear and concise information. The following questions and answers provide practical guidance for navigating the complexities of HbA1c targets in this population.
Question 1: Why are HbA1c targets sometimes higher for older adults compared to younger individuals?
Older adults are often more vulnerable to hypoglycemia, the risks of which can outweigh the benefits of very tight glycemic control. Higher targets help balance these risks, prioritizing safety and quality of life.
Question 2: How are individualized HbA1c targets determined for older adults?
Individualized targets consider factors such as age, comorbidities, functional status, life expectancy, and patient preferences. A thorough assessment of these factors informs clinical judgment, balancing the benefits of glycemic control with the risks of hypoglycemia and treatment burden.
Question 3: What are the risks of setting HbA1c targets too low in older adults?
Overly stringent targets can significantly increase the risk of hypoglycemia, leading to falls, confusion, and other adverse events. This can negatively impact functional status and overall well-being.
Question 4: What are the risks of setting HbA1c targets too high in older adults?
While less stringent targets minimize hypoglycemia risk, excessively high targets can increase the risk of long-term microvascular complications, such as retinopathy, nephropathy, and neuropathy, particularly in individuals with longer life expectancies.
Question 5: How often should HbA1c be monitored in older adults?
Monitoring frequency depends on individual factors like glycemic stability, medication regimen, and comorbidities. Generally, testing occurs every 2-6 months, with more frequent monitoring for individuals on intensive therapy or experiencing unstable glucose levels.
Question 6: How can patients actively participate in determining their HbA1c targets?
Open communication with healthcare providers is crucial. Patients should express their concerns, preferences, and treatment goals. Shared decision-making ensures targets align with individual values and priorities.
Individualized HbA1c targets, informed by a comprehensive understanding of patient-specific factors, promote safe and effective diabetes management in older adults. Open communication and shared decision-making are crucial for optimizing outcomes and enhancing quality of life.
The following sections delve deeper into specific aspects of managing diabetes in older adults, offering further insights and practical guidance.
Tips for Managing Glycemic Control in Older Adults
Maintaining optimal glycemic control in older adults requires a multifaceted approach. These tips offer practical guidance for healthcare professionals and caregivers navigating the complexities of diabetes management in this population.
Tip 1: Prioritize Individualized Glycemic Targets
Recognize that a “one-size-fits-all” approach is inappropriate. Individualized HbA1c targets, considering age, comorbidities, and functional status, are essential for safe and effective management.
Tip 2: Assess and Address Hypoglycemia Risk
Older adults are particularly vulnerable to hypoglycemia. Careful medication management, regular monitoring, and patient education are crucial for mitigating this risk.
Tip 3: Simplify Medication Regimens
Complex regimens can be challenging for older adults to manage. Streamlining medications, using combination therapies when appropriate, and providing clear instructions enhance adherence and minimize errors.
Tip 4: Emphasize Lifestyle Interventions
Promote regular physical activity, as tolerated, and a balanced diet rich in fruits, vegetables, and whole grains. These interventions can improve insulin sensitivity and contribute to better glycemic control.
Tip 5: Facilitate Regular Monitoring and Follow-up
Regular HbA1c testing and, if necessary, self-monitoring of blood glucose (SMBG) are vital. Frequent follow-up appointments enable timely adjustments to therapy based on monitoring data.
Tip 6: Incorporate Shared Decision-Making
Engage patients in treatment decisions. Respecting patient preferences and values enhances adherence and promotes a patient-centered approach to care.
Tip 7: Address Cognitive and Functional Limitations
Cognitive impairment and functional limitations can impact diabetes self-management. Provide support and resources tailored to individual needs, such as medication organizers and simplified educational materials.
Tip 8: Collaborate with Interdisciplinary Teams
Effective diabetes management often requires a collaborative approach involving physicians, nurses, dietitians, pharmacists, and other healthcare professionals. Coordinated care optimizes outcomes and enhances patient support.
Implementing these tips facilitates comprehensive and patient-centered glycemic management in older adults. This approach optimizes outcomes, minimizes risks, and promotes overall well-being.
The concluding section synthesizes key takeaways and offers practical guidance for translating these principles into improved clinical practice.
Conclusion
Managing HbA1c in older adults requires a nuanced approach that departs from standardized targets applied to younger populations. This exploration has highlighted the critical interplay of age-related physiological changes, comorbidities, functional limitations, and patient preferences in determining appropriate glycemic goals. Prioritizing individualized HbA1c targets minimizes the risk of hypoglycemia while striving for acceptable glycemic control. Balancing these considerations remains central to optimizing both the quality and length of life in this vulnerable population. The discussion emphasized the importance of regular monitoring, shared decision-making, and a collaborative approach involving healthcare professionals, patients, and caregivers.
As the global population ages, the prevalence of diabetes in older adults continues to rise, underscoring the growing importance of refining glycemic management strategies. Further research investigating optimal HbA1c targets for specific subgroups within the elderly population, considering diverse comorbidities and functional statuses, remains crucial. Continued development of educational resources and clinical guidelines will empower healthcare providers to deliver patient-centered care, balancing treatment efficacy with individual needs and preferences. Ultimately, refining the understanding and application of individualized HbA1c targets promises to improve the well-being and health outcomes of older adults living with diabetes.
